A detailed history of First Bancorp, Inc transactions in Pfizer Inc stock. As of the latest transaction made, First Bancorp, Inc holds 17,486 shares of PFE stock, worth $467,051. This represents 0.35% of its overall portfolio holdings.

Number of Shares
17,486
Previous 17,886 2.24%
Holding current value
$467,051
Previous $500,000 1.2%
% of portfolio
0.35%
Previous 0.37%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$27.7 - $31.39 $11,080 - $12,556
-400 Reduced 2.24%
17,486 $506,000
Q2 2024

Jul 23, 2024

BUY
$25.26 - $29.6 $96,619 - $113,220
3,825 Added 27.2%
17,886 $500,000
Q1 2024

Apr 15, 2024

BUY
$25.89 - $29.73 $7,844 - $9,008
303 Added 2.2%
14,061 $390,000
Q4 2023

Jan 23, 2024

SELL
$26.13 - $33.94 $97,726 - $126,935
-3,740 Reduced 21.37%
13,758 $396,000
Q3 2023

Oct 23, 2023

SELL
$32.09 - $37.51 $3,209 - $3,751
-100 Reduced 0.57%
17,498 $580,000
Q2 2023

Jul 19, 2023

SELL
$36.12 - $41.79 $10,836 - $12,537
-300 Reduced 1.68%
17,598 $645,000
Q1 2023

Apr 24, 2023

BUY
$39.39 - $51.28 $74,368 - $96,816
1,888 Added 11.79%
17,898 $730,000
Q4 2022

Feb 01, 2023

SELL
$41.75 - $54.5 $8,350 - $10,900
-200 Reduced 1.23%
16,010 $820,000
Q3 2022

Oct 24, 2022

BUY
$43.76 - $53.42 $56,888 - $69,446
1,300 Added 8.72%
16,210 $709,000
Q2 2022

Jul 14, 2022

BUY
$46.53 - $55.17 $45,692 - $54,176
982 Added 7.05%
14,910 $782,000
Q1 2022

Apr 25, 2022

SELL
$45.75 - $56.69 $2,058 - $2,551
-45 Reduced 0.32%
13,928 $721,000
Q4 2021

Jan 28, 2022

SELL
$41.32 - $61.25 $88,672 - $131,442
-2,146 Reduced 13.31%
13,973 $825,000
Q3 2021

Oct 19, 2021

BUY
$39.25 - $50.42 $25,826 - $33,176
658 Added 4.26%
16,119 $694,000
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $517,788 - $583,961
15,461 New
15,461 $560,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track First Bancorp, Inc Portfolio

Follow First Bancorp, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bancorp, Inc , based on Form 13F filings with the SEC.

News

Stay updated on First Bancorp, Inc with notifications on news.